![Biao He](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Biao He
Directeur/Bestuurslid bij BioEclipse Therapeutics, Inc.
Actieve functies van Biao He
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BioEclipse Therapeutics, Inc.
![]() BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Directeur/Bestuurslid | - | - |
Loopbaan van Biao He
Eerdere bekende functies van Biao He
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Tsinghua Silicon Valley Capital
![]() Tsinghua Silicon Valley Capital Investment ManagersFinance Tsinghua Silicon Valley Capital (TEEC Angel Management) is a venture capital firm founded in 2010 by Eugene Zhang and Chun Xia. The firm is headquartered in Los Altos, California. | Private Equity Investor | - | - |
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sectoraal
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Tsinghua Silicon Valley Capital
![]() Tsinghua Silicon Valley Capital Investment ManagersFinance Tsinghua Silicon Valley Capital (TEEC Angel Management) is a venture capital firm founded in 2010 by Eugene Zhang and Chun Xia. The firm is headquartered in Los Altos, California. | Finance |
BioEclipse Therapeutics, Inc.
![]() BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Health Technology |